Newsroom
Baio receives CHF 40,000 from Venture Kick to scale AI-driven molecular design platform
23.02.2026
Baio Labs receives CHF 40,000 from Venture Kick to advance Drugon, its generative AI platform for structure-based molecular design. Powered by a large-scale 3D diffusion model, Drugon enables medicinal chemists to design and validate novel ... En savoir plus
Dental Robotics receives CHF 40,000 from Venture Kick to advance mobile dental system engineering
23.02.2026
Dental Robotics receives CHF 40,000 from Venture Kick to advance its ultra-lightweight mobile dental hygiene system. The 3-in-1 solution enables high-quality dental care outside traditional practices, supporting scalable deployment for mobi ... En savoir plus
Baxiva receives CHF 150,000 from Venture Kick to develop first-in-class Escherichia Coli vaccine
23.02.2026
ETH spin-off Baxiva has obtained CHF 150,000 from Venture Kick to advance a new vaccine designed to prevent diseases caused by Escherichia coli (E. coli). The biotech startup aims to tackle one of the major drivers of antibiotic resistance ... En savoir plus
Archive Newsletter
Kicking Finish, Bold Outlook?
Not cooling off! ??
Autumn is Hot ! ??
Communiqués de Presse
Press review
Contact medias
Pour toute question ou demande médias, veuillez envoyer un email à notre équipe de communication. Si vous avez une question d’ordre général sur Venture Kick, veuillez voir notre page contact.
Vous pouvez obtenir davantage d’informations sur Venture Kick ici ou télécharger le rapport annuel ici.